查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587527

兽用抗生素市场规模、份额和趋势分析报告：2025-2030 年按动物类型、药物类别、剂型、地区和细分市场预测

Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), By Drug Class (Tetracyclines, Penicillins), By Dosage Form, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 258 Pages | 商品交期: 2-10个工作天内

价格

兽用抗生素市场成长及趋势

预计2030年，全球兽用抗生素市场规模将达59.1亿美元，预计2025年至2030年复合年增长率为2.54%。

市场成长的主要驱动力包括对专用抗生素和离子载体的日益关注、主要企业不断增加的倡议和新产品的推出以及牲畜疾病发病率的增加。由于一些较旧的抗生素与抗药性有关，主要企业正在大力推出新的抗生素来满足需求。例如，2023年1月，Norbrook推出了Tulieve，一种注射用泰拉霉素的非专利药，用于治疗肉牛、非泌乳乳牛和猪的细菌感染疾病。

同样，2021年12月，维克推出了用于猪和牛呼吸道疾病的抗生素药物「Tulicin」。这些产品现已提供给欧洲的兽医。因此，抗生素开发的研究、开发和製造目前正在进行中，预计这种情况将持续下去，不会很快完全停止。这有助于市场的成长。

进一步加速未来市场成长的机会之一是新抗生素的发现。兽医仍需要新的抗生素来对抗新出现的抗药性菌株。该领域的研究和开发有可能带来突破性药物，解决动物感染疾病治疗中未满足的需求。据美国农业部称，创新药物的开发可以减少抗药性以及食用动物生产中对现有抗生素的需求。此外，伴同性动物对药物的需求也可能推动伴同性动物市场而不是食用动物新产品的开发。同时，对美国肉类出口需求的增加加剧了全球化带来的动物疾病挑战，而动物抗生素抗药性的发展可能会推动对抗生素的需求和新抗生素的开发。

此外，主要兽用抗生素製造商面临全球学名药开发商的激烈竞争。这些学名药因其成本效益也给製造商带来了价格压力。当抗生素专利到期时，学名药开发商将替代配方推向市场。例如，Elanco 的 Maxiban（离子载体/专用抗生素）截至 2021 年没有专利保护，因此竞争对手可能会开始开发非专利的、成本较低的替代品。同样，硕腾在 2021 年报告称，一旦产品专利到期，它将面临学名药开发商的竞争。因此，该公司被迫降低价格并为其核心产品提供折扣，以与市场上更便宜的非专利替代品竞争。因此，从长远来看，日益激烈的非专利竞争预计将对市场构成挑战。

此外，人们对牲畜疾病的认识不断提高，预计将增加医院和诊所对兽医治疗的需求，从而导致对兽用抗生素的需求增加。例如，安大略省大约有 5,247 名兽医，其次是不列颠哥伦比亚省，有 1,650 名兽医。此外，用于治疗牲畜的抗生素必须符合加拿大卫生署的动物安全标准。兽医可以从多种抗生素中进行选择，旨在预防或减轻威胁动物的疾病的严重程度。所有在该国销售的抗生素都必须经过加拿大食品检验局的批准。这些因素预计将推动市场成长。

兽用抗生素市场报告亮点

  • 按动物类型划分，2024 年，牛细分市场占据压倒性的市场占有率，达到 39.69%。牛肉和乳製品消费的增加是推动这一领域的关键因素。
  • 以药品类别来看，四环霉素在兽用抗生素市场占据主导地位，2024年份额为29.04%。四环霉素是一种常用的兽用抗生素。
  • 2024年，口服液细分市场占据市场主导地位。口服溶液或溶液是兽用抗生素最容易开发和使用的剂型。
  • 北美兽用抗生素市场2024年收益占有率最大，为32.37%。该区域市场可能是由于现有参与企业的存在以及兽医诊所对治疗的需求不断增加而推动的。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 兽用抗生素市场波动趋势及范围

  • 市场体系展望
    • 母市场
    • 辅助市场
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 兽用抗生素市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 法律规范
    • 主要兽用抗生素专利到期日分析
    • 产品平臺分析
    • 2023年欧洲国家抗菌VMP（活性成分）总量预估（吨）
    • 2023 年欧洲生产动物中按抗菌类别分類的抗菌活性物质的估计数量
    • COVID-19 影响分析

第四章兽用抗生素市场：动物类型、估计与趋势分析

  • 细分仪表板
  • 兽用抗生素市场：以动物类型的波动分析
  • 2018-2030年按动物类型分類的兽用抗生素市场规模与趋势分析
  • 牛
  • 猪
  • 绵羊和山羊
  • 家禽
  • 其他的

第五章兽用抗生素市场：药物类别、估计与趋势分析

  • 细分仪表板
  • 兽用抗生素市场：依药物类别波动分析
  • 2018-2030年兽用抗生素市场规模及趋势分析（依药物类别）
    • 四环霉素
    • 青霉素
    • 磺胺类药物
    • 青霉素
    • 大环内酯
    • 甲氧芐啶
    • 林可酰胺
    • 多粘菌素
    • Aminoglycosides
    • Fluoroquinolones
    • Pleuromutilin
    • 其他的

第六章兽用抗生素市场：剂型、估算与趋势分析

  • 细分仪表板
  • 兽用抗生素市场：剂型差异分析
  • 2018-2030年兽用抗生素市场规模及趋势分析（按剂型）
    • 口服粉剂
    • 口服液
    • 注射
    • 其他的

第七章兽用抗生素市场：区域、估计和趋势分析

  • 区域仪表板
  • 2024年和2030年按地区分類的兽用抗生素市场占有率，百万美元
  • 区域展望
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
    • 比利时
    • 匈牙利
    • 波兰
    • 葡萄牙
    • 罗马尼亚
    • 荷兰
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国

第八章 竞争格局

  • 市场参与企业分类
  • 企业市场分析/堆图分析
  • 公司简介
    • Merck &Co., Inc.
    • Ceva Sante Animale.
    • Vetoquinol
    • Zoetis Services LLC
    • Boehringer Ingelheim International GmbH
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Virbac SA
    • Calier.
    • Bimeda, Inc
    • Prodivet Pharmaceuticals SA/NV
    • Norbrook Laboratories
  • 策略规划
    • 併购
    • 伙伴关係与协作
    • 扩张
    • 产品发布
    • 产品核可
    • 其他的
  • List of Other Players
Product Code: GVR-4-68040-298-9

Veterinary Antibiotics Market Growth & Trends:

The global veterinary antibiotics market size is expected to reach USD 5.91 billion in 2030 and is anticipated to grow at a CAGR of 2.54% from 2025 to 2030. The primary drivers of market growth include a rising focus on animal-only antibiotics and ionophores, growing initiatives by key companies and the launch of new products, and the increasing incidence of livestock diseases. Key players are significantly launching new antibiotics to meet the demand, as some of the older antibiotics have been associated with resistance. For instance, in January 2023, Norbrook launched Tulieve, a generic tulathromycin injection for treating bacterial infections in beef cattle, nonlactating dairy cattle, and swine.

Similarly, in December 2021, Virbac launched Tulissin, an antibiotic solution for swine and cattle with respiratory pathologies. These products were made available for European veterinarians. Therefore, R&D and manufacturing for antibiotic development are ongoing, which is anticipated to continue without a complete halt anytime soon. This factor is contributing to the market growth.

One of the opportunities to further accelerate market growth in the future is the discovery of novel antibiotics. There is a continuous need for new antibiotics to combat emerging resistant strains in veterinary medicine. Research and development in this area could lead to breakthrough drugs that address unmet needs in treating animal infections. According to the U.S. Department of Agriculture, the development of innovative drugs could reduce resistance and the need for existing antibiotics in the production of food animals. Moreover, the need for medications intended for companion animals may promote the development of novel products for that market rather than for use in food animals. On the other hand, increasing export demand for U.S. meat is intensifying animal illness challenges caused by globalization, and the development of antibiotic resistance in animals could boost the demand for antibiotics and the development of new antibiotics.

Moreover, major veterinary antibiotic manufacturers are facing severe competition from generic drug developers globally. These generic products also create pricing pressure on manufacturers owing to their cost-effectiveness. As the patent for antibiotic products expires, generic drug developers introduce alternative forms of products into the market. For instance, Elanco's Maxiban (an ionophore/animal-only antibiotic) has no patent protection as of 2021, thus, competitors might begin to develop generic & lower-priced alternatives. Similarly, Zoetis reported in 2021 that the company faces competition from generic product developers once a product's patent expires. As a result, the company has been compelled to reduce its prices and provide discounts for major products to compete with the lower-priced alternative generic products available in the market. Therefore, increasing generic competition is expected to create challenges in the market in the long run.

In addition, the rising awareness of livestock diseases is predicted to create a demand for veterinary treatment in hospitals & clinics, creating a requirement for veterinary antibiotics. For instance, Ontario has approximately 5,247 veterinarians, followed by 1,650 in British Columbia. Furthermore, antibiotics used for livestock treatment must meet Health Canada's human & animal safety standards. Veterinarians can choose from various antibiotics designed to help prevent or lower the severity of diseases that threaten animals. Every antibiotic marketed in the country must be licensed by the Canadian Food Inspection Agency. Such factors are likely to propel market growth.

Veterinary Antibiotics Market Report Highlights:

  • Based on animal type, the cattle segment held the dominant market share of 39.69% in 2024. Increased consumption of beef and dairy products is a major factor expected to drive the segment.
  • Based on drug class,the tetracyclines segment dominated the veterinary antibiotics market in 2024 with a share of 29.04%. Tetracyclines are a class of commonly used veterinary antibiotics.
  • The oral solutions segment dominated the market in 2024. Oral liquids or solutions are among the easiest dosage forms of veterinary antibiotics to develop and use.
  • The veterinary antibiotics market in North America accounted for the largest revenue share of 32.37% in 2024. This regional market is likely to be driven by the presence of established players and increasing demand for treatment among veterinary practices.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Antibiotics Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising focus on animal-only antibiotics and ionophores
      • 3.2.1.2. Growing Initiatives by key companies And launch of new products
      • 3.2.1.3. Increasing Incidence of Livestock Diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulations
      • 3.2.2.2. Decline In the use of antibiotics
      • 3.2.2.3. Rising research on antibiotic alternatives
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Antibiotics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental Landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Patent-Off Dates Analysis for Major Veterinary Antibiotics
    • 3.3.5. Product Pipeline Analysis
    • 3.3.6. Overall Estimated Sales Of Antimicrobial VMPs (Active Substance) In Tonnes By European Country, 2023
    • 3.3.7. Estimated Sales Of Antimicrobial Active Substances in Production Animals in Europe, By Antimicrobial Class, 2023
    • 3.3.8. COVID-19 Impact Analysis

Chapter 4. Veterinary Antibiotics Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Antibiotics Market: Animal Type Movement Analysis
  • 4.3. Veterinary Antibiotics Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
  • 4.4. Cattle
    • 4.4.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pigs
    • 4.5.1. Pigs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Sheep & Goat
    • 4.6.1. Sheep & Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Poultry
    • 4.7.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Antibiotics Market: Drug Class Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Antibiotics Market: By Drug Class Movement Analysis
  • 5.3. Veterinary Antibiotics Market Size & Trend Analysis, by drug class, 2018 to 2030 (USD Million)
    • 5.3.1. Tetracyclines
      • 5.3.1.1. Tetracyclines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Penicillins
      • 5.3.2.1. Penicillins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Sulfonamides
      • 5.3.3.1. Sulfonamides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Penicillins
      • 5.3.4.1. Penicillins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Macrolides
      • 5.3.5.1. Macrolides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Trimethoprim
      • 5.3.6.1. Trimethoprim Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Lincosamides
      • 5.3.7.1. Lincosamides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.8. Polymyxins
      • 5.3.8.1. Polymyxins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.9. Aminoglycosides
      • 5.3.9.1. Aminoglycosides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.10. Fluoroquinolones
      • 5.3.10.1. Fluoroquinolones Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.11. Pleuromutilins
      • 5.3.11.1. Pleuromutilins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.12. Others
      • 5.3.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Antibiotics Market: Dosage Form Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Antibiotics Market: By Dosage Form Movement Analysis
  • 6.3. Veterinary Antibiotics Market Size & Trend Analysis, by dosage form, 2018 to 2030 (USD Million)
    • 6.3.1. Oral Powders
      • 6.3.1.1. Oral Powders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Oral solutions
      • 6.3.2.1. Oral Solutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Injections
      • 6.3.3.1. Injections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Antibiotics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Veterinary Antibiotics Market Share, By Region, 2024 & 2030, USD Million
  • 7.3. Regional Outlook
  • 7.4. North America
    • 7.4.1. North America Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. U.S. Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Canada Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. UK Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Germany Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. France Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Italy Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Spain Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Denmark Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Sweden Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Norway Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Belgium
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Belgium Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Hungary
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Hungary Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Poland
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Poland Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Portugal
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Portugal Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Romania
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Romania Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.15. Netherlands
      • 7.5.15.1. Key Country Dynamics
      • 7.5.15.2. Romania Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Japan Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. China Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. India Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Australia Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. South Korea Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Brazil Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Mexico
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Mexico Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. Argentina
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Argentina Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. South Africa Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Saudi Arabia Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. UAE Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heap Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Merck & Co., Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Ceva Sante Animale.
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Vetoquinol
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Zoetis Services LLC
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Boehringer Ingelheim International GmbH
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Dechra Pharmaceuticals PLC
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Elanco Animal Health Incorporated
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Virbac S.A.
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Calier.
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Bimeda, Inc
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Prodivet Pharmaceuticals SA/NV
      • 8.3.11.1. Participant's Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Product Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Norbrook Laboratories
      • 8.3.12.1. Participant's Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Product Benchmarking
      • 8.3.12.4. Strategic Initiatives
  • 8.4. Strategy Mapping
    • 8.4.1. Mergers & Acquisitions
    • 8.4.2. Partnerships & Collaborations
    • 8.4.3. Expansion
    • 8.4.4. Product launch
    • 8.4.5. Product Approval
    • 8.4.6. Others
  • 8.5. List of Other Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Veterinary Antibiotics market, by region, 2018 - 2030 (USD Million)
  • Table 3 Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 4 Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 5 Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 6 North America Veterinary Antibiotics market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 8 North America Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 9 North America Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 10 U.S. Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 12 U.S. Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 13 Canada Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 14 Canada Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 15 Canada Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 16 Europe Veterinary Antibiotics market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 18 Europe Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 19 Europe Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 20 Germany Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 21 Germany Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 22 Germany Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 23 UK Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 24 UK Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 25 UK Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 26 France Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 27 France Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 28 France Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 29 Italy Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 30 Italy Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 31 Italy Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 32 Spain Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 33 Spain Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 34 Spain Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 35 Denmark Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 36 Denmark Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 37 Denmark Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 38 Sweden Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 39 Sweden Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 40 Sweden Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 41 Norway Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 42 Norway Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 43 Norway Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 44 Netherlands Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 45 Netherlands Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 46 Netherlands Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 47 Belgium Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 48 Belgium Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 49 Belgium Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 50 Portugal Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 51 Portugal Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 52 Portugal Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 53 Hungary Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 54 Hungary Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 55 Hungary Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 56 Poland Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 57 Poland Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 58 Poland Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 59 Romania Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 60 Romania Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 61 Romania Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Veterinary Antibiotics market, by country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 66 China Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 67 China Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 68 China Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 69 Japan Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 70 Japan Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 71 Japan Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 72 India Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 73 India Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 74 India Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 75 South Korea Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 77 South Korea Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 78 Australia Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 79 Australia Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 80 Australia Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 81 Latin America Veterinary Antibiotics market, by country, 2018 - 2030 (USD Million)
  • Table 82 Latin America Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 83 Latin America Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 84 Latin America Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 85 Brazil Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 86 Brazil Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 87 Brazil Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 88 Mexico Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 89 Mexico Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 90 Mexico Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 91 Argentina Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 92 Argentina Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 93 Argentina Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 94 MEA Veterinary Antibiotics market, by country, 2018 - 2030 (USD Million)
  • Table 95 MEA Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 96 MEA Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 97 MEA Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 98 South Africa Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 99 South Africa Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 100 South Africa Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 101 Saudi Arabia Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 102 Saudi Arabia Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 103 Saudi Arabia Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 104 UAE Veterinary Antibiotics market, by Animal type, 2018 - 2030 (USD Million)
  • Table 105 UAE Veterinary Antibiotics market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 106 UAE Veterinary Antibiotics market, by Dosage Form, 2018 - 2030 (USD Million)
  • Table 107 Company Overview
  • Table 108 Product Benchmarking
  • Table 109 Financial Performance
  • Table 110 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Veterinary Antibiotics Market Revenue, 2018-2030 (USD Million)
  • Fig. 10 Veterinary Antibiotics Market snapshot
  • Fig. 11 Veterinary Antibiotics Market driver impact
  • Fig. 12 Veterinary Antibiotics Market restraint impact
  • Fig. 13 Veterinary Antibiotics animal type key takeaways (USD Million)
  • Fig. 14 Veterinary Antibiotics market animal Type movement analysis
  • Fig. 15 cattle market, 2018 - 2030 (USD Million)
  • Fig. 16 pigs market, 2018 - 2030 (USD Million)
  • Fig. 17 Sheep & Goat market, 2018 - 2030 (USD Million)
  • Fig. 18 poultry market, 2018 - 2030 (USD Million)
  • Fig. 19 others market, 2018 - 2030 (USD Million)
  • Fig. 20 Veterinary Antibiotics Market Drug class key takeaways (USD Million)
  • Fig. 21 Veterinary Antibiotics market: Drug class movement analysis
  • Fig. 22 Tetracyclines market, 2018 - 2030 (USD Million)
  • Fig. 23 Penicillin's market, 2018 - 2030 (USD Million)
  • Fig. 24 Sulfonamides market, 2018 - 2030 (USD Million)
  • Fig. 25 Macrolides market, 2018 - 2030 (USD Million)
  • Fig. 26 Trimethoprim market, 2018 - 2030 (USD Million)
  • Fig. 27 Lincosamides market, 2018 - 2030 (USD Million)
  • Fig. 28 Polymyxins market, 2018 - 2030 (USD Million)
  • Fig. 29 Aminoglycosides market, 2018 - 2030 (USD Million)
  • Fig. 30 Fluoroquinolones market, 2018 - 2030 (USD Million)
  • Fig. 31 Pleuromutilins market, 2018 - 2030 (USD Million)
  • Fig. 32 Others market, 2018 - 2030 (USD Million)
  • Fig. 33 Veterinary Antibiotics Market by Dosage Form key takeaways (USD Million)
  • Fig. 34 Veterinary Antibiotics market by Dosage Form movement analysis
  • Fig. 35 Oral powders market, 2018 - 2030 (USD Million)
  • Fig. 36 Oral Solutions, 2018 - 2030 (USD Million)
  • Fig. 37 Injections market, 2018 - 2030 (USD Million)
  • Fig. 38 Others market, 2018 - 2030 (USD Million)
  • Fig. 39 Regional market place: Key takeaways
  • Fig. 40 Regional outlook, 2024 & 2030
  • Fig. 41 North America Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 43 Canada Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 47 France Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 53 Netherlands Companion Animal Health market, 2018 - 2030 (USD Million)
  • Fig. 54 Belgium companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 55 Hungary companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 56 Poland companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 57 Portugal companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 58 Romania Companion Animal Health market, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 61 China Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
  • Fig. 62 India Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 63 Australia Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korean Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 67 Mexico Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 69 MEA Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 72 UAE Veterinary Antibiotics market, 2018 - 2030 (USD Million)
  • Fig. 73 Market participant categorization